Retaturide- 12mg

Retaturide – GGG Tri-Agonist Research Peptide (GLP-1 / GIP / Glucagon)

Retaturide is a next-generation tri-agonist peptide designed to simultaneously activate GLP-1, GIP, and glucagon receptors. This triple-targeted mechanism has placed Retaturide at the forefront of metabolic and weight management research. Preliminary studies suggest it may promote rapid and sustained reductions in body weight—potentially exceeding those of existing incretin-based therapies—by combining enhanced energy expenditure with appetite suppression.